5499-67-2

Basic information

• Product Name: 5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE
• Synonyms: 5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE;5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBOXALDEHYDE;AKOS BBS-00001926
• CAS NO: 5499-67-2
• Molecular Formula: C₁₆H₁₁ClN₂O
• Molecular Weight: 282.72
• Mol File: 5499-67-2.mol
• Article Data: 19

Chemical Properties

• Melting Point: 109 °C
• Boiling Point: 462.9°C at 760 mmHg
• Flash Point: 233.8°C
• Appearance: /
• Density: 1.24g/cm³
• Vapor Pressure: 9.46E-09mmHg at 25°C
• Refractive Index: 1.634
• CAS DataBase Reference: 5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE(5499-67-2)
• EPA Substance Registry System: 5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE(5499-67-2)

Safety Data

• Hazardous Substances Data: 5499-67-2(Hazardous Substances Data)

Usage

Description

5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE is a chemical compound with the molecular formula C19H13ClN2O. It is a pyrazole derivative that features a chloro group, two phenyl rings, and an aldehyde functional group. This unique structure endows it with potential applications in various fields, particularly in the pharmaceutical industry for the development of new drugs. Additionally, it may serve as a valuable starting material in organic synthesis and chemical research.

Uses

Used in Pharmaceutical Industry:
5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE is used as a key intermediate in the synthesis of new drugs, leveraging its distinctive chemical structure to create novel therapeutic agents.
Used in Organic Synthesis:
In the realm of organic synthesis, 5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE is utilized as a starting material for the creation of a variety of other compounds, contributing to the development of new chemical entities.
Used in Chemical Research:
5-CHLORO-1,3-DIPHENYL-1H-PYRAZOLE-4-CARBALDEHYDE also serves as a valuable component in chemical research, where its properties and reactivity are studied to further scientific understanding and innovation.

InChI:InChI=1/C16H11ClN2O/c17-16-14(11-20)15(12-7-3-1-4-8-12)18-19(16)13-9-5-2-6-10-13/h1-11H

Upstream product

• 4845-49-2 1,3-diphenyl-5-oxo-4,5-dihydro-1H-pyrazole 
• 10025-87-3 trichlorophosphate 
• 68-12-2 N,N-dimethyl-formamide 
• 100-63-0 phenylhydrazine 
• 98-86-2 acetophenone 
• 583-11-9 N-(1-phenylethylidene)phenylhydrazine 
• 94-02-0 ethyl 3-oxo-3-phenylpropionate 
• 114138-49-7 5-hydroxy-3-phenyl-1-(phenyl)-1H-pyrazole 
• 119887-96-6 (E)-3-(5-Chloro-1,3-diphenyl-1H-pyrazol-4-yl)-1-p-tolyl-propenone 
• 119887-95-5 (E)-3-(5-Chloro-1,3-diphenyl-1H-pyrazol-4-yl)-1-phenyl-propenone 

Downstream Products

• 136506-65-5 5-azido-1,3-diphenyl-1H-pyrazole-4-carbaldehyde 
• 1660146-11-1 2-((5-morpholino-1,3-diphenyl-1H-pyrazol-4-yl)methylene)malononitrile 
• 1660146-12-2 2-(1,3-diphenyl-5-piperidin-1-yl-1H-pyrazol-4-ylmethylene)malononitrile 
• 1660146-16-6 1,3-diphenyl-1,4,5a,6,8,9-hexahydro-5H-pyrazolo[4',3':5,6]pyrido[2,1-c][1,4]oxazine-5,5-dicarbonitrile 
• 1660146-17-7 1,3-diphenyl-1,4,6,7,8,9-hexahydropyrazolo[4,3-c]quinolizine-5,5(5aH)-dicarbonitrile 
• 1660146-08-6 1,3-diphenyl-5-piperidino-1H-pyrazole-4-carbaldehyde 
• 1660146-07-5 5-morpholin-4-yl-1,3-diphenyl-1H-pyrazole-4-carbaldehyde 
• 493021-44-6 2-[(2-hydroxyethyl)(1,3-diphenyl-1H-pyrazolo[3,4-b]quinolin-6-ylmethyl)amino]ethanol 

Relevant articles and documents

Synthesis of Selenopyrano[2,3- c ]pyrazol-4(1 H)-ones and Their C-H Activation

We disclose the synthesis of selenopyrano[2,3- c ]pyrazol-4(1 H)-ones and their aryl derivatives for the first time by using selenopyran ring formation via an in situ-generated selenide that reacts directly with α-halo-β-ynone-bearing substituted pyrazole

New hydrazone derivatives of pyrazole-4-carboxaldehydes exhibited anti-inflammatory properties

Background: Several series of hydrazone derivatives of pyrazole-4-carboxaldehydes (4-11) were designed and synthesized to screen their inflammatory activity. Methods: The products were characterized by1H NMR,13C NMR and HRMS. In vitro LPS-induced TNF-α model and in vivo xylene-induced ear-edema model were used to evaluate their anti-inflammatory activity. Results and Conclusion: Bioassays indicated that most of the compounds markedly inhibited the expression of TNF-α at the concentration of 10 μg/mL. Compounds 7b and 11c, two of the most potent compounds, exhibited TNF-α inhibitory ability in a dose-dependent manner with IC50 values of 5.56 and 3.69 μM, respectively. In vivo, intraperitoneal administration with 7b and 11c markedly inhibited the ear edema at the doses of 20 and 50 mg/kg. Compound 11c, inhibited edema by 49.59 % at the dose of 20 mg/kg, was comparable to the reference drug dexamethasone at the same dose (with an inhibition of 50.49 %). To understand the binding pattern, molecular docking of representa-tive 7b and 11c was performed, which demonstrated that both compounds have a forceful binding with the TNF-α, and that the phenyl and hydrazide moieties of them play a significant role in binding with the target site.

Microwave-accelerated and Catalyst-free Synthesis of Novel tris-(Pyrazolyl)methanes

-